[(2H-1,3-benzodioxol-5-yl)methyl](prop-2-en-1-yl)amine, 95.0%, 1g

2-Chloro-N-(furan-2-ylmethyl)-N-(2,2,2-trifluoroethyl)acetamide, 98%, 250mg

(S)-tert-butyl 2-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)pyrrolidine-1-carboxylate, 97%, 1g

1-(4-Bromobutyl)-4-fluorobenzene, 97%, 250mg

CHAPS 10% solution, sterile-filtered, 5g

2-(2-(Pyridin-2-yl)-1H-imidazol-4-yl)ethan-1-amine dihydrochloride, 97%, 250mg

2-Fluoro-2-methylpropan-1-ol, 97%, 10g

Methyl N-(tert-Butoxycarbonyl)-3-[(3S)-2-oxo-3-pyrrolidinyl]-L-alaninate>98.0%(HPLC)(T)25g

1-(4-fluorophenyl)-4-(3-phenyl-1,2,4-oxadiazol-5-yl)pyrrolidin-2-one, 95.0%, 250mg

3,4-Dimethoxybenzonitrile, 95.0%, 5g

Ethyl 2-(2-chloropropanoylamino)benzoate, 98%, 2g

2-Amino-4-fluoro-5-methylbenzonitrile, 95+%, 1g

4-Chloro-1-(2,5-difluorophenyl)butan-1-one, 97%, 25g